{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T21:11:47Z","timestamp":1784927507624,"version":"3.55.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,8]],"date-time":"2023-09-08T00:00:00Z","timestamp":1694131200000},"content-version":"vor","delay-in-days":7,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005925","name":"Buddhist Tzu Chi Medical Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100022298","name":"Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation","doi-asserted-by":"publisher","award":["IMAR-109-01-04-03"],"award-info":[{"award-number":["IMAR-109-01-04-03"]}],"id":[{"id":"10.13039\/501100022298","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100022298","name":"Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation","doi-asserted-by":"publisher","award":["IMAR-110-01-14"],"award-info":[{"award-number":["IMAR-110-01-14"]}],"id":[{"id":"10.13039\/501100022298","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heliyon"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.heliyon.2023.e20011","type":"journal-article","created":{"date-parts":[[2023,9,9]],"date-time":"2023-09-09T05:45:53Z","timestamp":1694238353000},"page":"e20011","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Development and evaluation of a novel chromium III-based compound for potential inhibition of emerging SARS-CoV-2 variants"],"prefix":"10.1016","volume":"9","author":[{"given":"Yu-Jung","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Navaneethan","family":"Sundhar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hema Sri","family":"Devi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsueh-Fa","family":"Pien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shina Fong-Mei","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenn-Line","family":"Sheu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce Chi-Kang","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2347-0411","authenticated-orcid":false,"given":"Chih-Yang","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10224","key":"10.1016\/j.heliyon.2023.e20011_bib1","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S0140-6736(20)30251-8","article-title":"Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding","volume":"395","author":"Lu","year":"2020","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.heliyon.2023.e20011_bib2","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1056\/NEJMoa2001017","article-title":"A novel coronavirus from patients with pneumonia in China, 2019","volume":"382","author":"Zhu","year":"2020","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.heliyon.2023.e20011_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2020.105924","article-title":"Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): the epidemic and the challenges","volume":"55","author":"Lai","year":"2020","journal-title":"Int. J. Antimicrob. Agents"},{"issue":"7798","key":"10.1016\/j.heliyon.2023.e20011_bib4","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41586-020-2012-7","article-title":"A pneumonia outbreak associated with a new coronavirus of probable bat origin","volume":"579","author":"Zhou","year":"2020","journal-title":"Nature"},{"issue":"13","key":"10.1016\/j.heliyon.2023.e20011_bib5","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1001\/jama.2021.3199","article-title":"SARS-CoV-2 vaccines","volume":"325","author":"Creech","year":"2021","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.heliyon.2023.e20011_bib6","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1001\/jama.2021.24315","article-title":"Winter of Omicron\u2014the evolving COVID-19 pandemic","volume":"327","author":"Del Rio","year":"2022","journal-title":"JAMA"},{"key":"10.1016\/j.heliyon.2023.e20011_bib7","series-title":"Investigating the Aggressiveness of the COVID-19 Omicron Variant and Suggestions for Possible Treatment Options","author":"Mohiuddin","year":"2021"},{"issue":"4","key":"10.1016\/j.heliyon.2023.e20011_bib8","doi-asserted-by":"crossref","first-page":"821","DOI":"10.3390\/cells10040821","article-title":"Role of structural and non-structural proteins and therapeutic targets of SARS-CoV-2 for COVID-19","volume":"10","author":"Yadav","year":"2021","journal-title":"Cells"},{"issue":"2","key":"10.1016\/j.heliyon.2023.e20011_bib9","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","article-title":"SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor","volume":"181","author":"Hoffmann","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.heliyon.2023.e20011_bib10","first-page":"47","article-title":"Peptide and peptide-based inhibitors of SARS-CoV-2 entry, Adv. Drug Deliv","volume":"167","author":"Schutz","year":"2020","journal-title":"Rev. E."},{"issue":"6493","key":"10.1016\/j.heliyon.2023.e20011_bib11","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1126\/science.abb9332","article-title":"Rapid repurposing of drugs for COVID-19","volume":"368","author":"Guy","year":"2020","journal-title":"Science"},{"issue":"10","key":"10.1016\/j.heliyon.2023.e20011_bib12","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1177\/2472555220942123","article-title":"RNA-dependent RNA polymerase as a target for COVID-19 drug discovery","volume":"25","author":"Zhu","year":"2020","journal-title":"SLAS Discov"},{"issue":"10339","key":"10.1016\/j.heliyon.2023.e20011_bib13","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1016\/S0140-6736(22)00519-0","article-title":"Remdesivir and three other drugs for hospitalised patients with COVID-19: final results of the WHO Solidarity randomised trial and updated meta-analyses","volume":"399","author":"Consortium","year":"2022","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.heliyon.2023.e20011_bib14","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1056\/NEJMoa2116044","article-title":"Molnupiravir for oral treatment of Covid-19 in nonhospitalized patients","volume":"386","author":"Jayk Bernal","year":"2022","journal-title":"N. Engl. J. Med."},{"issue":"15","key":"10.1016\/j.heliyon.2023.e20011_bib15","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1056\/NEJMoa2118542","article-title":"Oral nirmatrelvir for high-risk, nonhospitalized adults with Covid-19","volume":"386","author":"Hammond","year":"2022","journal-title":"N. Engl. J. Med."},{"issue":"19","key":"10.1016\/j.heliyon.2023.e20011_bib16","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1056\/NEJMoa2001282","article-title":"A trial of lopinavir\u2013ritonavir in adults hospitalized with severe Covid-19","volume":"382","author":"Cao","year":"2020","journal-title":"N. Engl. J. Med."},{"issue":"1147","key":"10.1016\/j.heliyon.2023.e20011_bib17","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1136\/postgradmedj-2020-138577","article-title":"COVID-19: current understanding of its pathophysiology, clinical presentation and treatment","volume":"97","author":"Parasher","year":"2021","journal-title":"Postgrad. Med."},{"issue":"2","key":"10.1016\/j.heliyon.2023.e20011_bib18","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1038\/s41590-021-01104-y","article-title":"Pathological sequelae of long-haul COVID","volume":"23","author":"Mehandru","year":"2022","journal-title":"Nat. Immunol."},{"issue":"7","key":"10.1016\/j.heliyon.2023.e20011_bib19","doi-asserted-by":"crossref","first-page":"4050","DOI":"10.3390\/ijms23074050","article-title":"Identification of entry inhibitors against delta and omicron variants of SARS-CoV-2","volume":"23","author":"Lee","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"8","key":"10.1016\/j.heliyon.2023.e20011_bib20","doi-asserted-by":"crossref","first-page":"2800","DOI":"10.3390\/nu13082800","article-title":"Hesperidin is a potential inhibitor against SARS-CoV-2 infection","volume":"13","author":"Cheng","year":"2021","journal-title":"Nutrients"},{"key":"10.1016\/j.heliyon.2023.e20011_bib21","doi-asserted-by":"crossref","DOI":"10.1186\/s12986-020-0432-x","article-title":"Tetramethylpyrazine reverses high-glucose induced hypoxic effects by negatively regulating HIF-1\u03b1 induced BNIP3 expression to ameliorate H9c2 cardiomyoblast apoptosis","volume":"17","author":"Liu","year":"2020","journal-title":"Nutr. Metab."},{"issue":"6","key":"10.1016\/j.heliyon.2023.e20011_bib22","doi-asserted-by":"crossref","DOI":"10.1111\/jfbc.13666","article-title":"Resveratrol inhibited the metastatic behaviors of cisplatin\u2010resistant human oral cancer cells via phosphorylation of ERK\/p\u201038 and suppression of MMP\u20102\/9","volume":"45","author":"Chang","year":"2021","journal-title":"J. Food Biochem."},{"issue":"12","key":"10.1016\/j.heliyon.2023.e20011_bib23","doi-asserted-by":"crossref","first-page":"2502","DOI":"10.1097\/HJH.0000000000003285","article-title":"Angiotensin II prompts heart cell apoptosis via AT1 receptor-augmented phosphatase and tensin homolog and miR-320-3p functions to enhance suppression of the IGF1R-PI3K-AKT survival pathway","volume":"40","author":"Lu","year":"2022","journal-title":"J. Hypertens."},{"issue":"3","key":"10.1016\/j.heliyon.2023.e20011_bib24","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1002\/tox.23717","article-title":"Insulin\u2010like growth factor II receptor alpha overexpression in heart aggravates hyperglycemia\u2010induced cardiac inflammation and myocardial necrosis","volume":"38","author":"Lai","year":"2023","journal-title":"Environ. Toxicol."},{"key":"10.1016\/j.heliyon.2023.e20011_bib25","first-page":"1","article-title":"Estimating the impact of drug addiction causes heart damage","author":"Chang","year":"2022","journal-title":"Drug Chem. Toxicol."},{"issue":"4","key":"10.1016\/j.heliyon.2023.e20011_bib26","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1016\/j.apsb.2021.06.016","article-title":"Recent advances in developing small-molecule inhibitors against SARS-CoV-2","volume":"12","author":"Xiang","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"issue":"1","key":"10.1016\/j.heliyon.2023.e20011_bib27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12985-021-01624-x","article-title":"Keep out! SARS-CoV-2 entry inhibitors: their role and utility as COVID-19 therapeutics","volume":"18","author":"Chitsike","year":"2021","journal-title":"Virol. J."},{"key":"10.1016\/j.heliyon.2023.e20011_bib28","article-title":"Glycopeptide antibiotic teicoplanin inhibits cell entry of SARS-CoV-2 by suppressing the proteolytic activity of cathepsin L","volume":"13","author":"Yu","year":"2022","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.heliyon.2023.e20011_bib29","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.632677","article-title":"An update on antiviral therapy against SARS-CoV-2: how far have we come?","volume":"12","author":"Indari","year":"2021","journal-title":"Front. Pharmacol."},{"issue":"68","key":"10.1016\/j.heliyon.2023.e20011_bib30","first-page":"1","article-title":"Primum non nocere\u2013Are chloroquine and hydroxychloroquine safe prophylactic\/treatment options for SARS-CoV-2 (covid-19)?","volume":"54","author":"Biguetti","year":"2020","journal-title":"Rev. Saude Publica"},{"key":"10.1016\/j.heliyon.2023.e20011_bib31","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/7341493","article-title":"Paxlovid: mechanism of action, synthesis, and in silico study","volume":"2022","author":"Marzi","year":"2022","journal-title":"BioMed Res. Int."},{"issue":"4","key":"10.1016\/j.heliyon.2023.e20011_bib32","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.mjafi.2020.08.004","article-title":"Favipiravir: a new and emerging antiviral option in COVID-19","volume":"76","author":"Agrawal","year":"2020","journal-title":"Med. J. Armed Forces India"}],"container-title":["Heliyon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844023072195?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844023072195?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T21:00:16Z","timestamp":1784926816000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405844023072195"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":32,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["S2405844023072195"],"URL":"https:\/\/doi.org\/10.1016\/j.heliyon.2023.e20011","relation":{},"ISSN":["2405-8440"],"issn-type":[{"value":"2405-8440","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development and evaluation of a novel chromium III-based compound for potential inhibition of emerging SARS-CoV-2 variants","name":"articletitle","label":"Article Title"},{"value":"Heliyon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.heliyon.2023.e20011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e20011"}}